These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 38651004)

  • 1. Quality assessment of the MRI-radiomics studies for MGMT promoter methylation prediction in glioma: a systematic review and meta-analysis.
    Doniselli FM; Pascuzzo R; Mazzi F; Padelli F; Moscatelli M; Akinci D'Antonoli T; Cuocolo R; Aquino D; Cuccarini V; Sconfienza LM
    Eur Radiol; 2024 Feb; ():. PubMed ID: 38308012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative radiomic analysis for pre-surgical prognostic stratification of glioblastoma patients: from advanced to basic MRI protocols.
    Bakas S; Shukla G; Akbari H; Erus G; Sotiras A; Rathore S; Sako C; Min Ha S; Rozycki M; Singh A; Shinohara R; Bilello M; Davatzikos C
    Proc SPIE Int Soc Opt Eng; 2020 Feb; 11315():. PubMed ID: 33746333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AI-driven estimation of O6 methylguanine-DNA-methyltransferase (MGMT) promoter methylation in glioblastoma patients: a systematic review with bias analysis.
    Samartha MVS; Dubey NK; Jena B; Maheswar G; Lo WC; Saxena S
    J Cancer Res Clin Oncol; 2024 Jan; 150(2):57. PubMed ID: 38291266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State of Radiomics in Glioblastoma.
    Taha B; Boley D; Sun J; Chen CC
    Neurosurgery; 2021 Jul; 89(2):177-184. PubMed ID: 33913492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDPNet: a radiomic feature learning method with epigenetic application to estimating MGMT promoter methylation status in glioblastoma.
    Guo J; Yu F; Nasrallah MP; Davatzikos C
    Proc SPIE Int Soc Opt Eng; 2024 Feb; 12930():. PubMed ID: 38651004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of A Radiomic Model for
    Doniselli FM; Pascuzzo R; Agrò M; Aquino D; Anghileri E; Farinotti M; Pollo B; Paterra R; Cuccarini V; Moscatelli M; DiMeco F; Sconfienza LM
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine learning-based radiomic, clinical and semantic feature analysis for predicting overall survival and MGMT promoter methylation status in patients with glioblastoma.
    Lu Y; Patel M; Natarajan K; Ughratdar I; Sanghera P; Jena R; Watts C; Sawlani V
    Magn Reson Imaging; 2020 Dec; 74():161-170. PubMed ID: 32980505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomics signature: A potential biomarker for the prediction of MGMT promoter methylation in glioblastoma.
    Xi YB; Guo F; Xu ZL; Li C; Wei W; Tian P; Liu TT; Liu L; Chen G; Ye J; Cheng G; Cui LB; Zhang HJ; Qin W; Yin H
    J Magn Reson Imaging; 2018 May; 47(5):1380-1387. PubMed ID: 28926163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-sequence and habitat-based MRI radiomics signature for preoperative prediction of MGMT promoter methylation in astrocytomas with prognostic implication.
    Wei J; Yang G; Hao X; Gu D; Tan Y; Wang X; Dong D; Zhang S; Wang L; Zhang H; Tian J
    Eur Radiol; 2019 Feb; 29(2):877-888. PubMed ID: 30039219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiogenomic classification for MGMT promoter methylation status using multi-omics fused feature space for least invasive diagnosis through mpMRI scans.
    Qureshi SA; Hussain L; Ibrar U; Alabdulkreem E; Nour MK; Alqahtani MS; Nafie FM; Mohamed A; Mohammed GP; Duong TQ
    Sci Rep; 2023 Feb; 13(1):3291. PubMed ID: 36841898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The University of Pennsylvania glioblastoma (UPenn-GBM) cohort: advanced MRI, clinical, genomics, & radiomics.
    Bakas S; Sako C; Akbari H; Bilello M; Sotiras A; Shukla G; Rudie JD; Santamaría NF; Kazerooni AF; Pati S; Rathore S; Mamourian E; Ha SM; Parker W; Doshi J; Baid U; Bergman M; Binder ZA; Verma R; Lustig RA; Desai AS; Bagley SJ; Mourelatos Z; Morrissette J; Watt CD; Brem S; Wolf RL; Melhem ER; Nasrallah MP; Mohan S; O'Rourke DM; Davatzikos C
    Sci Data; 2022 Jul; 9(1):453. PubMed ID: 35906241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overall Survival Prediction in Glioblastoma With Radiomic Features Using Machine Learning.
    Baid U; Rane SU; Talbar S; Gupta S; Thakur MH; Moiyadi A; Mahajan A
    Front Comput Neurosci; 2020; 14():61. PubMed ID: 32848682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fully automated artificial intelligence method for non-invasive, imaging-based identification of genetic alterations in glioblastomas.
    Calabrese E; Villanueva-Meyer JE; Cha S
    Sci Rep; 2020 Jul; 10(1):11852. PubMed ID: 32678261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI to MGMT: predicting methylation status in glioblastoma patients using convolutional recurrent neural networks.
    Han L; Kamdar MR
    Pac Symp Biocomput; 2018; 23():331-342. PubMed ID: 29218894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Learning MRI-based classification models for MGMT methylation status prediction in glioblastoma.
    Kanas VG; Zacharaki EI; Thomas GA; Zinn PO; Megalooikonomou V; Colen RR
    Comput Methods Programs Biomed; 2017 Mar; 140():249-257. PubMed ID: 28254081
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.